Conmed (CNMD) Amortization of Deferred Charges (2019 - 2026)

Conmed's Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• Quarterly Amortization of Deferred Charges fell 11.57% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (down 4.48% YoY) and the FY2025 annual result came in at $5.6 million, down 0.95% from the prior year.
• Amortization of Deferred Charges was $1.3 million for Q1 2026 at Conmed, down from $1.5 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $1.5 million in Q3 2023 and bottomed at $880000.0 in Q1 2022.
• A 5-year average of $1.4 million and a median of $1.4 million in 2024 frame the typical range for Amortization of Deferred Charges.
• Peak annual rise in Amortization of Deferred Charges reached 93.08% in 2022, while the deepest fall reached 16.82% in 2022.
• Conmed's Amortization of Deferred Charges stood at $1.5 million in 2022, then retreated by 0.4% to $1.5 million in 2023, then fell by 3.73% to $1.4 million in 2024, then advanced by 6.58% to $1.5 million in 2025, then dropped by 17.09% to $1.3 million in 2026.
• Business Quant data shows CNMD's Amortization of Deferred Charges at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $1.3 million in Q3 2025.